The expand Podcast: Pulmonary Arterial Hypertension
- PHA Canada

- 2 days ago
- 2 min read
Pulmonary arterial hypertension (PAH) is rare, serious—and too often misunderstood. In Season 6 of The eXpand Podcast, advocates and medical experts explore why this life-threatening illness is frequently misdiagnosed, how it reshapes lives, and what new treatments offer for the future.
Across three powerful episodes, the series reveals the personal, emotional, and clinical sides of PAH—bringing attention to an “invisible illness” that deserves to be seen, heard, and better understood.
Episode 1: Pulmonary Arterial Hypertension: A Deadly Missed Diagnosis
Guest: Jamie Myrah, Executive Director of PHA Canada
Jamie shares insights from the patient community, highlighting why early symptoms like unexplained breathlessness are so often dismissed—and how late diagnosis impacts lives. This episode touches on the emotional toll, the need for earlier recognition, and the power of advocacy and connection.
🔍 Learn about:
What PAH is and how it differs from other forms of PH
Why it often takes 2+ years to diagnose
How delayed diagnosis affects mental health
The importance of timely access to primary care
Episode 2: Pulmonary Arterial Hypertension in Canada: Diagnosis and Care
Guest: Dr. Sanjay Mehta
In conversation with Dr. Sanjay Mehta, this episode dives into the clinical challenges of diagnosing PAH in Canada. It highlights the role of classification, why symptoms are often overlooked, and how collaboration between specialists leads to better outcomes.
🔍 Learn about:
How PH and PAH are classified and why it matters
Why multidisciplinary care is essential
How to recognize early red flags in clinical settings
Episode 3: Pulmonary Arterial Hypertension Management: The Role of Early Diagnosis
Guest: Dr. Nathan Brunner
Dr. Brunner, a cardiologist, explains the cardiology perspective on PAH and why early diagnosis is key to improving long-term outcomes. From early detection to integrated care models, this episode is a must-listen for both patients and healthcare providers.
🔍 Learn about:
Why delayed diagnosis remains common
How early intervention reduces treatment burden
When to suspect PAH in patients with unexplained dyspnea




Comments